Results 101 to 110 of about 16,260 (178)

β-Aminopropioamidoximes derivatives as potential antitubercular agents against anthropozoonotic infections caused by <i>Mycobacterium tuberculosis</i> and <i>Mycobacterium bovis</i>. [PDF]

Vet World
Kayukova L, Bismilda V, Turgenbayev K, Uzakova A, Baitursynova G, Jussipbekov U, Mukanova M, Chingissova L, Dyussembayeva G, Borsynbayeva A, Yerlanuly A, Auyezov A.   +11 more
europepmc   +1 more source

Synthesis and structure-activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents. [PDF]

Bioorg Med Chem Lett
Yang B, Sukheja P, Qin B, Li G, Bare GAL, Cascioferro A, Love MS, Petrassi HM, Sharpless KB, McNamara CW, Chatterjee AK.   +10 more
europepmc   +1 more source

Identification of 2-(N-aryl-1,2,3-triazol-4-yl) quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity. [PDF]

Front Chem
Sabt A, Abdulla MH, Ebaid MS, Pawełczyk J, Abd El Salam HA, Son NT, Ha NX, Vaali Mohammed MA, Traiki T, Elsawi AE, Dziadek B, Dziadek J, Eldehna WM.   +12 more
europepmc   +1 more source

Identification of benzothiazones containing a hexahydropyrrolo[3,4-c]pyrrol moiety as antitubercular agents against MDR-MTB. [PDF]

RSC Adv, 2020
Ma X, Han B, Wang A, Yang L, Huang M, Chowdhury K, Gu J, Zhang K, Lv K.   +8 more
europepmc   +1 more source

Synthesis, molecular docking study and biological evaluation of new pyrrole scaffolds as potential antitubercular agents for dual targeting of enoyl ACP reductase and dihydrofolate reductase. [PDF]

PLoS One
Mahnashi MH, Avunoori S, Gopi S, Shaikh IA, Saif A, Bantun F, Faidah HS, Alhadi AA, Alshehri JH, Alharbi AA, S R PK, Joshi SD.   +11 more
europepmc   +1 more source

Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-<i>N</i>-oxide derivatives as potential antitubercular agents. [PDF]

RSC Med Chem
González-González A, Sánchez-Sánchez O, Wan B, Franzblau S, Palos I, Espinoza-Hicks JC, Moreno-Rodríguez A, Martínez-Vázquez AV, Lara-Ramírez EE, Ortiz-Pérez E, Paz-González AD, Rivera G.   +11 more
europepmc   +1 more source

Synthesis, evaluation, molecular docking, and molecular dynamics studies of novel N-(4-[pyridin-2-yloxy]benzyl)arylamine derivatives as potential antitubercular agents. [PDF]

Drug Dev Res, 2020
Verma R, Boshoff HIM, Arora K, Bairy I, Tiwari M, Varadaraj BG, Shenoy GG.   +6 more
europepmc   +1 more source

Acyloxybenzyl and Alkoxyalkyl Prodrugs of a Fosmidomycin Surrogate as Antimalarial and Antitubercular Agents. [PDF]

ACS Med Chem Lett, 2018
Courtens C, Risseeuw M, Caljon G, Cos P, Van Calenbergh S.   +4 more
europepmc   +1 more source

New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents. [PDF]

J Enzyme Inhib Med Chem, 2019
Chiarelli LR, Mori M, Beretta G, Gelain A, Pini E, Sammartino JC, Stelitano G, Barlocco D, Costantino L, Lapillo M, Poli G, Caligiuri I, Rizzolio F, Bellinzoni M, Tuccinardi T, Villa S, Villa S, Meneghetti F.   +17 more
europepmc   +1 more source

Identification of N-Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 as Antitubercular Agents. [PDF]

ACS Med Chem Lett, 2018
Li L, Lv K, Yang Y, Sun J, Tao Z, Wang A, Wang B, Wang H, Geng Y, Liu M, Guo H, Lu Y.   +11 more
europepmc   +1 more source